SEARCH

SEARCH BY CITATION

References

  • Acarin L., Vela J. M., Gonzalez B. and Castellano B. (1994) Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding. J. Histochem. Cytochem. 42, 10331041.
  • Aoun P., Simpkins J. W. and Agarwal N. (2003) Role of PPAR-γ ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 44, 29993004.
  • Barone F. C. and Feuerstein G. Z. (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819834.
  • Bernardo A., Levi G. and Minghetti L. (2000) Role of the peroxisome proliferator-activated receptor-γ (PPAR-γ) and its natural ligand 15-deoxy-Δ12, 14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 12, 22152223.
  • Cao G., Pei W., Ge H., Liang Q., Luo Y., Frank F. R., Lu A., Ran R., Graham S. H. and Chen J. (2002) In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22, 54235431.
  • Carmel J. B., Galante A., Soteropoulos P., Tolias P., Recce M., Young W. and Hart R. P. (2001) Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol. Genomics 7, 201213.
  • Chen H., Chopp M., Zhang R. L., Bodzin G., Chen Q., Rusche J. R. and Todd R. F. 3rd (1994) Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 35, 458463.
  • Chen J., Graham S. H., Nakayama M., Zhu R. L., Jin K., Stetler R. A. and Simon R. P. (1997) Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J. Cereb. Blood Flow Metab. 17, 210. (Published erratum appears in J. Cereb. Blood Flow Metab. (1998); 18: preceding 931.)
  • Chopp M., Zhang R. L. and Jiang N. (1996) The role of adhesion molecules in reducing cerebral ischemic cell damage. Adv. Neurol. 71, 315327.
  • Connolly E. S. Jr, Winfree C. J., Springer T. A., Naka Y., Liao H., Yan S. D., Stern D. M., Solomon R. A., Gutierrez-Ramos J. C. and Pinsky D. J. (1996) Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209216.
  • Cristiano L., Bernardo A. and Ceru M. P. (2001) Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes. J. Neurocytol. 30, 671683.
  • Cuzzocrea S., Pisano B., Dugo L. et al. (2003a) Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut. Br. J. Pharmacol. 140, 366376.
  • Cuzzocrea S., Mazzon E., Dugo L. et al. (2003b) Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum. 48, 35443556.
  • Day C. (1999) Thiazolidinediones: a new class of anti-diabetic drugs. Diabet. Med. 16, 179192.
  • Dehmer T., Heneka M. T., Sastre M., Dichgans J. and Schulz J. B. (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation. J. Neurochem. 88, 494501.
  • Desvergne B. and Wahli W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649688.
  • Diab A., Deng C., Smith J. D., Hussain R. Z., Phanavanh B., Lovett-Racke A. E., Drew P. D. and Racke M. K. (2002) Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 168, 25082515.
  • Dirnagl U., Iadecola C. and Moskowitz M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391397.
  • Fahmi H., Di Battista J. A., Pelletier J. P., Mineau F., Ranger P. and Martel-Pelletier J. (2001) Peroxisome proliferator-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum. 44, 595607.
  • Feinstein D. L., Galea E., Gavrilyuk V., Brosnan C. F., Whitacre C. C., Dumitrescu-Ozimek L., Landreth G. E., Pershadsingh H. A., Weinberg G. and Heneka M. T. (2002) Peroxisome proliferator-activated receptor-γ agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51, 694702.
  • Fuenzalida K. M., Aguilera M. C., Piderit D. G., Ramos P. C., Contador D., Quinones V., Rigotti A., Bronfman F. C. and Bronfman M. (2005) Peroxisome proliferator-activated receptor γ is a novel target of the nerve growth factor signaling pathway in PC12 cells. J. Biol. Chem. 280, 96049609.
  • Gao Y., Signore A. P., Yin W., Cao G., Yin X. M., Sun F., Luo Y., Graham S. H. and Chen J. (2005) Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J. Cereb. Blood Flow Metab. 25, 694712.
  • Goussev A. V., Zhang Z., Anderson D. C. and Chopp M. (1998) P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat. J. Neurol. Sci. 161, 1622.
  • Heneka M. T., Klockgether T. and Feinstein D. L. (2000) Peroxisome proliferator-activated receptor-γ ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J. Neurosci. 20, 68626867.
  • Iadecola C. and Alexander M. (2001) Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14, 8994.
  • Inestrosa N. C., Godoy J. A., Quintanilla R. A., Koenig C. S. and Bronfman M. (2005) Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration: role of Wnt signaling. Exp. Cell Res. 304, 91104.
  • Ito H., Nakano A., Kinoshita M. and Matsumori A. (2003) Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia/reperfusion injury in a rat model. Lab. Invest. 83, 17151721.
  • Jean W. C., Spellman S. R., Nussbaum E. S. and Low W. C. (1998) Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery 43, 13821397.
  • Jiang C., Ting A. T. and Seed B. (1998) PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 8286.
  • Jin D. Q., Lim C. S., Hwang J. K., Ha I. and Han J. S. (2005) Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochem. Bioph. Res. Com. 331, 12641269.
  • Kaczorowski S. L., Schiding J. K., Toth C. A. and Kochanek P. M. (1995) Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 15, 860864.
  • Kariko K., Weissman D. and Welsh F. A. (2004) Inhibition of toll-like receptor and cytokine signaling – a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24, 12881304.
  • Kawahito Y., Kondo M., Tsubouchi Y., Hashiramoto A., Bishop-Bailey D., Inoue K., Kohno M., Yamada R., Hla T. and Sano H. (2000) 15-deoxy-Δ(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 106, 189197.
  • Kiaei M., Kipiani K., Chen J., Calingasan N. Y. and Beal M. F. (2005) Peroxisome proliferator-activated receptor-γ agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 191, 331336.
  • Lan J., Li W., Zhang F., Sun F. Y., Nagayama T., O'Horo C. and Chen J. (2003) Inducible repair of oxidative DNA lesions in the rat brain after transient focal ischemia and reperfusion. J. Cereb. Blood Flow Metab. 23, 13241339.
  • Landreth G. E. and Heneka M. T. (2001) Anti-inflammatory actions of peroxisome proliferator-activated receptor γ agonists in Alzheimer's disease. Neurobiol. Aging 22, 937944.
  • Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M. and Kliewer S. A. (1995) An anti-diabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12 95312 956.
  • Li R., Huang Y. G., Fang D. and Le W. D. (2004) (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J. Neurosci. Res. 78, 723731.
  • Lin Y., Huang R., Chen L. P., Lisoukov H., Lu Z. H., Li S., Wang C. C. and Huang R. P. (2003) Profiling of cytokine expression by biotin-labeled-based protein arrays. Proteomics 3, 17501757.
  • Luna-Medina R., Cortes-Canteli M., Alonso M., Santos A., Martinez A. and Perez-Castillo A. (2005) Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor γ activation. J. Biol. Chem. 280, 21 45321 462.
  • Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T., Hori M. and Matsumoto M. (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31, 17351743.
  • Mori E., del Zoppo G. J., Chambers J. D., Copeland B. R. and Arfors K. E. (1992) Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 23, 712718.
  • Murakami K., Kondo T., Kawase M., Li Y., Sato S., Chen S. F. and Chan P. H. (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18, 205213.
  • Nakajima A., Wada K., Miki H. et al. (2001) Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120, 460469.
  • Niino M., Iwabuchi K., Kikuchi S., Ato M., Morohashi T., Ogata A., Tashiro K. and Onoe K. (2001) Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ. J. Neuroimmunol. 116, 4048.
  • Nolan Y., Martin D., Campbell V. A. and Lynch M. A. (2004) Evidence of a protective effect of phosphatidylserine-containing liposomes on lipopolysaccharide-induced impairment of long-terin potentiation in the rat hippocampus. J. Neuroimmunol. 151, 1223.
  • Okada M., Yan S. F. and Pinsky D. J. (2002) Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J. 16, 18611868.
  • Plutzky J. (2003) The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis. Am. J. Cardiol. 92, 34J41J.
  • Ricote M., Li A. C., Willson T. M., Kelly C. J. and Glass C. K. (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 7982.
  • Sanguino E., Ramon M., Roglans N., Alegret M., Sanchez R. M., Vazquez-Carrera M. and Laguna J. C. (2003) Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe. Life Sci. 73, 29272937.
  • Saubermann L. J., Nakajima A., Wada K., Zhao S., Terauchi Y., Kadowaki T., Aburatani H., Matsuhashi N., Nagai R. and Blumberg R. S. (2002) Peroxisome proliferator-activated receptor γ agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm. Bowel Dis. 8, 330339.
  • Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H. and Greenberg J. H. (2005) A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36, 353359.
  • Sivarajah A., Chatterjee P. K., Patel N. S., Todorovic Z., Hattori Y., Brown P. A., Stewart K. N., Mota-Filipe H., Cuzzocrea S. and Thiemermann C. (2003) Agonists of peroxisome-proliferator activated receptor-γ reduce renal ischemia/reperfusion injury. Am. J. Nephrol. 23, 267276.
  • Soriano S. G., Coxon A., Wang Y. F., Frosch M. P., Lipton S. A., Hickey P. R. and Mayadas T. N. (1999) Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 30, 134139.
  • Spiegelman B. M. (1998) PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507514.
  • Sundararajan S., Gamboa J. L., Victor N. A., Wanderi E. W., Lust W. D. and Landreth G. E. (2005) Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130, 685696.
  • Suzuki H., Hayashi T., Tojo S. J., Kitagawa H., Kimura K., Mizugaki M., Itoyama Y. and Abe K. (1999) Anti-P-selectin antibody attenuates rat brain ischemic injury. Neurosci. Lett. 265, 163166.
  • Tontonoz P., Hu E. and Spiegelman B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 11471156.
  • Uryu S., Harada J., Hisamoto M. and Oda T. (2002) Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons. Brain Res. 924, 229236.
  • Wayman N. S., Ellis B. L. and Thiemermann C. (2002) Ligands of the peroxisome proliferator-activated receptor PPAR-α reduce myocardial infarct size. Med. Sci. Monit. 8, BR243247.
  • Yang G., Chan P. H., Chen J., Carlson E., Chen S. F., Weinstein P., Epstein C. J. and Kamii H. (1994) Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25, 165170.
  • Yang G. Y., Liu X. H., Kadoya C., Zhao Y. J., Mao Y., Davidson B. L. and Betz A. L. (1998) Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J. Cereb. Blood Flow Metab. 18, 840847.
  • Yenari M. A., Kunis D., Sun G. H., Onley D., Watson L., Turner S., Whitaker S. and Steinberg G. K. (1998) Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia. Exp. Neurol. 153, 223233.
  • Yue T. L., Chen J., Bao W. et al. (2001) In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 104, 25882594.
  • Zhang L., Schallert T., Zhang Z. G., Jiang Q., Arniego P., Li Q. J., Lu M. and Chopp M. (2002) A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Meth. 117, 207214.
  • Zhang R. L., Chopp M., Li Y., Zaloga C., Jiang N., Jones M. L., Miyasaka M. and Ward P. A. (1994) Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44, 17471751.
  • Zhang R. L., Chopp M., Zhang Z. G., Phillips M. L., Rosenbloom C. L., Cruz R. and Manning A. (1996) E-selectin in focal cerebral ischemia and reperfusion in the rat. J. Cereb. Blood Flow Metab. 16, 11261136.
  • del Zoppo G. J. (1999) Anti-thrombotic treatments in acute ischemic stroke. Thromb. Haemost. 82, 938946.
  • del Zoppo G., Ginis I., Hallenbeck J. M., Iadecola C., Wang X. and Feuerstein G. Z. (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 10, 95112.
  • del Zoppo G. J., Becker K. J. and Hallenbeck J. M. (2001) Inflammation after stroke: is it harmful? Arch. Neurol. 58, 669672.